Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Heart Failure Without Diabetes
NCT03331861Phase 2Terminated
- Sponsor
- Columbia University
- Start
- Feb 2019
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in heart failure (HF) comparing Metformin with Placebo (2 arms). Primary endpoint: Minute Ventilation to Carbon Dioxide Production Slope at 6 months. Started Feb 2019; status: terminated.
02
Drugs
metformin
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT03331861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03331861.